Lisa Boggio to Hemorrhage
This is a "connection" page, showing publications Lisa Boggio has written about Hemorrhage.
Connection Strength
0.699
-
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice. Haemophilia. 2020 Jul; 26(4):637-642.
Score: 0.183
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843.
Score: 0.150
-
Clinical and laboratory phenotype variability in type 2M von Willebrand disease. J Thromb Haemost. 2017 08; 15(8):1559-1566.
Score: 0.149
-
Presentation and management of a stage Ia lung cancer patient with a paraneoplastic factor VIII inhibitor. Ann Thorac Surg. 2006 Jan; 81(1):362-4.
Score: 0.067
-
Identified unmet needs and proposed solutions in mild-to-moderate haemophilia: A summary of opinions from a roundtable of haemophilia experts. Haemophilia. 2021 Jan; 27 Suppl 1:25-32.
Score: 0.048
-
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A. Blood. 2016 08 04; 128(5):630-7.
Score: 0.035
-
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood. 2016 05 19; 127(20):2481-8.
Score: 0.034
-
Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial. Blood. 2016 04 07; 127(14):1761-9.
Score: 0.034